CEACAM5 and neoplasm: Although carcinoembryonic antigen (CEA) and cancer antigen 19–9 (CA19-9) are commonly used tumor markers, their positivity rates in early-stage GC are below 10%, making them insufficient for screening purposes [2, 3].